Cancer Research Horizons is partnering with Diamond Light Source, the UK’s national synchrotron, to build a world-leading fragment-based drug discovery programme.  Diamond Light Source accelerates electrons to near light speed, producing bright light that is directed into research instruments known as beamlines.   Cancer Research Horizons and its drug discovery site at Newcastle University have already […]